¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Ȱ"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
reactivated
ÀçȰ¼º-
reactivation
ÀçȰ¼ºÈ
reactivation tuberculosis
ÀçȰ¼ºÈ°áÇÙ
recruitment
1. ¹Ý»çÁ¡Áõ 2. À½·®Áö°¢Áõ°¡ 3. Ȱ¼º¿îµ¿´ÜÀ§Áõ°¡ 4. µ¿¿ø, º¸Ãæ
reflex arc
¹Ý»çȰ, ¹Ý»ç±Ã
rehabilitation
ÀçȰ
rehabilitation center
ÀçȰ¿ø, ÀçȰ¼¾ÅÍ
rehabilitation medicine
ÀçȰÀÇÇÐ
rehabilitation nursing
ÀçȰ°£È£
reinvocation
ÀçȰ¼ºÈ
respiratory capacity
È£Èí¿ë·®, ÆóȰ·®
retrocalcaneobursitis
¹ß²ÞÄ¡µÚÀ±È°³¶¿°, Á¾°ñÈÄÀ±È°³¶¿°
retrohyoid bursa
¸ñ»ÔµÚÀ±È°ÁÖ¸Ó´Ï, ¼³°ñÈij¶
specific activity
1. ºñ¹æ»ç´É 2. ºñ(Ýï)Ȱ¼ºµµ, °íÀ¯È°¼ºµµ
spherical gliding principle
°ø¹Ì²ô·³¿ø¸®, ±¸ÇüȰ°¿ø¸®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
metabolically active stone
´ë»çȰ¼ºµ¹
monophasic action potential
´Ü»óȰµ¿ÀüÀ§
MR active nuclei
ÀÚ±â°ø¸íȰ¼ºÇÙ
nonstriated muscle
¹Î¹«´Ì±ÙÀ°, ÆòȰ±Ù
rehabilitation medicine
ÀçȰÀÇÇÐ
smooth muscle
¹Î¹«´Ì±ÙÀ°, ÆòȰ±ÙÀ°
smooth pursuit eye movement
¸Å²ö¾È±¸ÃßÀû¿îµ¿, ¿øÈ°ÃßÁ¾´«¿îµ¿
synovial membrane
À±È°¸·
neurapophysis
½Å°æÈ°À¶±â
near field potential
±ÙÁ¢ºÎÀ§È°µ¿ÀüÀ§
nerve action potential
½Å°æÈ°µ¿Àü¾Ð
neuroactive substance
½Å°æÈ°¼º¹°Áú
rehabilitation nursing
ÀçȰ°£È£
opisthotonus
(¢¡opisthotonos) Ȱ¸ð¾ç°Á÷
orinotherapy
°íÁö´ë»ýȰ¿ä¹ý
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
fractionation
ȰºÐÇÒ(ÝÂùÜ).
functional activity
±â´É¼º Ȱ¼ºµµ<Ȱµ¿µµ>
gactosyltransferase isoenzyme II
°¥¶ôÅä½ÇÆ®¶õ½ºÆä¶óÁ¦µ¿Á¾<--µ¿È°>È¿¼Ò II
ganglioside activator protein
°»±Û¸®¿À»çÀ̵å Ȱ¼º´Ü¹éÁú
genetic reactivation
À¯ÀüÀû ÀçȰ¼ºÈ
glabella
¹Ì°£ ´«½çȰ»çÀÌ
glabrous
¸Å²öÇÑ, ÆòȰÇÑ
gliding
ȰÁÖ(üÁñË).
gliding motility
ȰÁֿ¼º
gliding movement
ȰÁֿ(üÁñËê¡ÔÑ).
glucagon activity
±Û·çÄ«°ïȰ¼ºµµ.
gonadopause
»ý½ÄȰµ¿Á¤Áö.
gonarthromeningitis
½½°üÀý Ȱ¾×¸·¿°(¡üÁäû دæú), ½½°üÀý ³ú¸·¿°.
greater sigmoid cavity ; incisura trochlearis
µµ¸£·¡ÆÐÀÓ, ȰÂ÷ÀýÈç.
guanosine triphosphate-activating protein
»ïÀλ걸¾Æ³ë½Å Ȱ¼º´Ü¹éÁú
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½